Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease

Neurobiology of Disease

Volumn 10, Issue 1, 2002, Pages 28-32

  Hartmann, Andreas ^a   Mouatt Prigent, Annick ^a   Vila, Miquel ^a   Abbas, Nacer ^a   Perier, Céline ^a   Faucheux, Baptiste A ^a   Vyas, Sheela ^b   Hirsch, Etienne C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

Apoptosis; Bcl xL; Mitochondria; Parkinson's disease

Indexed keywords

MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL XL;

ADULT; AGED; ARTICLE; AUTOPSY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOSOL; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MESENCEPHALON; MITOCHONDRIAL MEMBRANE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0036311251     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0494     Document Type: Article

References (19)

1. Bcl-2 protein expression as a marker of neuronal immaturity in postnatal primate brain
2. Mitochondria as the central control point of apoptosis
3. Ageing and Parkinson's disease: Substantia nigra regional selectivity
4. Function and expression of the Bcl-x gene in the developing and adult nervous system
5. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death
6. The apoptosis theory in Parkinson's disease-Revisited
7. The biochemistry of apoptosis
8. Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: An in situ hybridization study
9. Cell death mechanisms in Parkinson's disease
10. Understanding cell death in Parkinson's disease
11. Parkinson's disease. Second of two parts
12. Mitochondrial respiratory chain disorders II: Neurodegenerative disorders and nuclear gene defects
13. Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease
14. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
15. Over-expression of Bcl-2 attenuates MPP3, but not 6-OHDA, induced cell death in a dopaminergic neuronal cell line
16. Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress
17. Cell death and apoptosis regulating proteins in Parkinson's disease - A cautionary note
18. Herpes simplex virus-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo
19. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2